These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2355217)

  • 1. Decreased ferritin levels in brain in Parkinson's disease.
    Dexter DT; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees AJ; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1990 Jul; 55(1):16-20. PubMed ID: 2355217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
    Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
    Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
    Dexter DT; Wells FR; Lees AJ; Agid F; Agid Y; Jenner P; Marsden CD
    J Neurochem; 1989 Jun; 52(6):1830-6. PubMed ID: 2723638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra.
    Galazka-Friedman J; Bauminger ER; Koziorowski D; Friedman A
    Biochim Biophys Acta; 2004 Mar; 1688(2):130-6. PubMed ID: 14990343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.
    Faucheux BA; Martin ME; Beaumont C; Hunot S; Hauw JJ; Agid Y; Hirsch EC
    J Neurochem; 2002 Oct; 83(2):320-30. PubMed ID: 12423242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.
    Riederer P; Sofic E; Rausch WD; Schmidt B; Reynolds GP; Jellinger K; Youdim MB
    J Neurochem; 1989 Feb; 52(2):515-20. PubMed ID: 2911028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains.
    Connor JR; Snyder BS; Arosio P; Loeffler DA; LeWitt P
    J Neurochem; 1995 Aug; 65(2):717-24. PubMed ID: 7616228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain iron and ferritin in Parkinson's and Alzheimer's diseases.
    Jellinger K; Paulus W; Grundke-Iqbal I; Riederer P; Youdim MB
    J Neural Transm Park Dis Dement Sect; 1990; 2(4):327-40. PubMed ID: 2078310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
    Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
    Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered systemic iron metabolism in Parkinson's disease.
    Logroscino G; Marder K; Graziano J; Freyer G; Slavkovich V; LoIacono N; Cote L; Mayeux R
    Neurology; 1997 Sep; 49(3):714-7. PubMed ID: 9305329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease.
    Chen JC; Hardy PA; Kucharczyk W; Clauberg M; Joshi JG; Vourlas A; Dhar M; Henkelman RM
    AJNR Am J Neuroradiol; 1993; 14(2):275-81. PubMed ID: 8456699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy.
    Griffiths PD; Dobson BR; Jones GR; Clarke DT
    Brain; 1999 Apr; 122 ( Pt 4)():667-73. PubMed ID: 10219780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy.
    Visanji NP; Collingwood JF; Finnegan ME; Tandon A; House E; Hazrati LN
    J Parkinsons Dis; 2013; 3(4):523-37. PubMed ID: 24113558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.
    Sofic E; Riederer P; Heinsen H; Beckmann H; Reynolds GP; Hebenstreit G; Youdim MB
    J Neural Transm; 1988; 74(3):199-205. PubMed ID: 3210014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.
    Bartzokis G; Cummings JL; Markham CH; Marmarelis PZ; Treciokas LJ; Tishler TA; Marder SR; Mintz J
    Magn Reson Imaging; 1999 Feb; 17(2):213-22. PubMed ID: 10215476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.
    Dexter DT; Jenner P; Schapira AH; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S94-100. PubMed ID: 1510387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control.
    Koziorowski D; Friedman A; Arosio P; Santambrogio P; Dziewulska D
    Parkinsonism Relat Disord; 2007 May; 13(4):214-8. PubMed ID: 17275395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
    Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.